中国内镜杂志2017，Vol.23Issue(6)：30-33,4.DOI:10.3969/j.issn.1007-1989.2017.06.007
经皮肾镜同期治疗肾盂旁囊肿合并肾盂输尿管连接部狭窄的临床观察
Percutaneous micro-channel approach in treatment of pelvis side cyst and ureteropelvic junction obstruction simultaneously
周可义 1杨文增 2崔振宇 2赵春利2
作者信息
- 1. 河北大学,河北 保定 071000
- 2. 河北大学附属医院 泌尿外科,河北 保定 071000
- 折叠
摘要
Abstract
Objective To evaluate the efficacy and safety of percutaneous micro-channel approach in treatment of pelvis side cyst and ureteropelvic junction obstruction simultaneously. Methods 32 patients with unilateral solitary parapelvic cyst complicated with UPJO, including 25 cases with ipsilateral kidney stones. After percutaneous holmium laser lithotripsy for patients complicated with calculi, then performed incision and drainage through the channels for parapelvic cyst by holmium laser, and antegrade high pressure balloon dilatation for UPJO, drainage by hippocampal tube in 3 ~ 6 months postoperatively. The operation time of fenestration drainage of cyst, narrow hypertensive dilatation and postoperative hospital stay were analyzed. Results Compared with 1 month (46.17 ± 6.33), 3 months (40.47 ± 6.06), 6 months (33.81 ± 7.05), 9 months (28.95 ± 7.92) after surgery, there was a marked improvement of the separation coefficient of renal convergence, the difference was statistically significant (P < 0.05). And compared with 6 months after surgery, the data of 9 months after surgery has statistical significant differences (P < 0.05). The separation coefficient of renal convergence decreases as time goes on. Conclusions Percutaneous micro-channel approach in treatment of pelvis side cyst and ureteropelvic junction obstruction by the same time can effectively relieve symptoms and decrease the separation coefficient of renal convergence. It is safe and effective.关键词
经皮微通道/肾盂旁囊肿/肾盂输尿管连接部狭窄/钬激光/高压球囊扩张Key words
percutaneous micro-channel/pelviside cyst/ureteropelvic junction obstruction/holmium laser/high pressure balloon分类
医药卫生引用本文复制引用
周可义,杨文增,崔振宇,赵春利..经皮肾镜同期治疗肾盂旁囊肿合并肾盂输尿管连接部狭窄的临床观察[J].中国内镜杂志,2017,23(6):30-33,4.
